Osaic Holdings’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12K | Sell |
2,850
-11,075
| -80% | -$46.7K | ﹤0.01% | 5663 |
|
|
2025
Q1 | $109K | Buy |
13,925
+11,625
| +505% | +$90.8K | ﹤0.01% | 4098 |
|
|
2024
Q4 | $10.7K | Sell |
2,300
-4,400
| -66% | -$20.5K | ﹤0.01% | 5699 |
|
|
2024
Q3 | $36.1K | Sell |
6,700
-1,463
| -18% | -$7.89K | ﹤0.01% | 4945 |
|
|
2024
Q2 | $72K | Sell |
8,163
-4,107
| -33% | -$36.2K | ﹤0.01% | 4370 |
|
|
2024
Q1 | $144K | Buy |
12,270
+1,570
| +15% | +$18.4K | ﹤0.01% | 3953 |
|
|
2023
Q4 | $120K | Buy |
10,700
+2,200
| +26% | +$24.8K | ﹤0.01% | 4296 |
|
|
2023
Q3 | $57.5K | Sell |
8,500
-2,700
| -24% | -$18.3K | ﹤0.01% | 4892 |
|
|
2023
Q2 | $102K | Buy |
11,200
+3,265
| +41% | +$29.6K | ﹤0.01% | 4418 |
|
|
2023
Q1 | $51.3K | Sell |
7,935
-1,315
| -14% | -$8.5K | ﹤0.01% | 4929 |
|
|
2022
Q4 | $59K | Buy |
9,250
+3,200
| +53% | +$20.4K | ﹤0.01% | 4804 |
|
|
2022
Q3 | $38K | Buy |
6,050
+493
| +9% | +$3.1K | ﹤0.01% | 5087 |
|
|
2022
Q2 | $49K | Sell |
5,557
-27,543
| -83% | -$243K | ﹤0.01% | 4973 |
|
|
2022
Q1 | $279K | Sell |
33,100
-2,638
| -7% | -$22.2K | ﹤0.01% | 3742 |
|
|
2021
Q4 | $364K | Buy |
35,738
+23,568
| +194% | +$240K | ﹤0.01% | 3378 |
|
|
2021
Q3 | $237K | Sell |
12,170
-15,092
| -55% | -$294K | ﹤0.01% | 3747 |
|
|
2021
Q2 | $479K | Buy |
27,262
+19,280
| +242% | +$339K | ﹤0.01% | 3075 |
|
|
2021
Q1 | $94K | Buy |
7,982
+1,982
| +33% | +$23.3K | ﹤0.01% | 4390 |
|
|
2020
Q4 | $103K | Hold |
6,000
| – | – | ﹤0.01% | 4005 |
|
|
2020
Q3 | $62K | Buy |
6,000
+5,800
| +2,900% | +$59.9K | ﹤0.01% | 4142 |
|
|
2020
Q2 | $1K | Sell |
200
-100
| -33% | -$500 | ﹤0.01% | 5849 |
|
|
2020
Q1 | $1K | Buy |
+300
| New | +$1K | ﹤0.01% | 5763 |
|